Brainstorm Cell Therapeutics Inc. (BCLI)

0.4300 +0.0620 (+16.85%) 收市：04:00PM EDT

Brainstorm Cell Therapeutics Inc.

1325 Avenue of Americas
28th Floor
New York, NY 10019
United States
201 488 0460
https://www.brainstorm-cell.com

版塊: Healthcare
行業: Biotechnology
全職員工: 29

高階主管

名稱	頭銜	支付	行使價	出生年份
Mr. Chaim Lebovits	President & Co-CEO	878.78k	無	1971
Dr. Stacy R. Lindborg Ph.D.	Co-Chief Executive Officer	751.08k	無	1971
Dr. Irit Arbel DSc, Ph.D.	Co-Founder & Independent Vice Chair of the Board	無	無	1960
Ms. Alla Patlis CPA, M.B.A.	Interim CFO & Controller	130.92k	無	1987
Mr. Uri Yablonka	Executive VP, Chief Business Officer, Secretary & Director	247.06k	無	1977
Dr. Daniel Offen Ph.D.	Chief Scientific Advisor	無	無	無
Ms. Mary Kay Turner	Senior Vice President of Patient Advocacy & Government Affairs	無	無	無
Dr. Ibrahim Dagher M.D.	Executive VP & Chief Medical Officer	無	無	1969

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and enhance neurological function. It is developing NurOwn, which has completed Phase III clinical trial for the treatment of amyotrophic lateral sclerosis; Phase II clinical trial for the treatment of progressive multiple sclerosis; and for the treatment of alzheimer's disease, as well as for other neurodegenerative diseases. Brainstorm Cell Therapeutics Inc. was incorporated in 2000 and is headquartered in New York, New York.

公司管治

截至 2024年5月1日 止，Brainstorm Cell Therapeutics Inc. 的 ISS 管治質素評分為 5。 Pillar 分數正在審核中：9；董事會：3；股東權利：2；現金賠償：7。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。